Palatin Technologies
PTN
#10820
Rank
A$23.72 M
Marketcap
A$13.32
Share price
-2.60%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -A$9.22 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$12.88 Million. In 2025 the company made an earning of -A$13.83 Million, an increase over its 2024 earnings that were of -A$38.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.22 Million-33.3%
2025 -A$13.83 Million-64.29%
2024 -A$38.71 Million-16.9%
2023 -A$46.58 Million5.99%
2022 -A$43.95 Million-13.7%
2021 -A$50.93 Million33.25%
2020 -A$38.22 Million-172.11%
2019 A$52.99 M2352.33%
2018 A$2.16 M-94.13%
2017 A$36.82 M-154.92%
2016 -A$67.05 Million3.67%
2015 -A$64.68 Million878%
2014 -A$6.62 Million-72.64%
2013 -A$24.17 Million-33.11%
2012 -A$36.14 Million77.71%
2011 -A$20.34 Million
2003 -A$34.43 Million29.93%
2002 -A$26.5 Million36.18%
2001 -A$19.46 Million
1999 -A$16.15 Million6.04%
1998 -A$15.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.65 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.59 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.17 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.45 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.35 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.20 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$42.37 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$79.71 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA